We have been representing patients and their family in drug injury lawsuits for the past 16 years and this is our main practice area.
Drug injury legal compensation cases involve personal injury or wrongful death claims filed on behalf of people who, unfortunately, experienced a serious side effect, had an adverse drug reaction, or died from their use of a prescription medication.
Given our many years of experience handling these types of lawsuits we know drug injury cases deserve special attention.
Drug injury claims have a personal aspect which must be appreciated and respected by the attorney handling your case. At our law firm, we do not underestimate nor lose sight of the trust which is being placed in us by clients when they select us to represent them for their lawsuit against the responsible pharmaceutical company.
We will handle your drug injury case not only competently and professionally, but with genuine care and understanding. Any inquiries from our clients are responded to promptly, and telephone calls are always returned without delay.
If you, relatives, or friends need legal advice or legal representation for a personal injury lawsuit or a wrongful death lawsuit involving a drug side effect, the Law Offices of Thomas J. Lamb is here to help.
We encourage you to submit a Drug Injury Law Case Review — it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, or some other lawyer — about your case based on his many years of experience.
We handle these drug injury cases on a contingency fee basis, meaning that there is no payment for our legal services until we are successful in getting legal compensation for you.
While our office is in Wilmington, North Carolina, we have successfully handled drug injury lawsuits for people all over the United States.
It is important to note that we do not put our clients into large class actions. Rather we favor an individual lawsuit approach, which allows us to give personal attention to each of our clients, from start to finish.
In a rush? You can use our Quick Contact Form to tell us the basic information about your case.
Legal & Medical News: Featured Article
The federal court Fosamax – femur fracture MDL has been in a “holding pattern” while the parties wait for the appellate court to issue rulings on at least two appeals regarding the Fosamax label, or package insert, information about the femur fracture side effect. And for the New Jersey state court Fosamax litigation, it appears that the presiding judge is content on waiting for the federal appellate court rulings to be issued.
Back in June 2015 U.S. District Judge Freda Wolfson of the District of New Jersey dismissed the last remaining cases in the Fosamax – femur fracture federal court MDL. However, those cases — as well as some earlier dismissed Fosamax lawsuits concerning femur fractures — could be reinstated if plaintiffs win an appeal currently pending before the U.S. Court of Appeals for the Third Circuit.
One of the main legal issues in those pending appeals is whether Merck could have strengthened the Fosamax drug label warnings about this apparent femur fracture side effect.
This little bit of “new” information about the Fosamax – femur fracture litigation comes from Merck’s Form 10-Q SEC filing for the quarterly period ended June 30, 2016:
- The total number of pending femur fracture lawsuits filed against Merck is 4,400 — down 25, from 4,405 as of 3/31/16
- The Fosamax federal court MDL case total numbers — 20 pending and 1,035 dismissed, which are being appealed by plaintiffs — are the same as they were as of 3/31/16
- The total number of New Jersey cases is down 20, from 3,040 as of 3/31/16
- The total number of California cases is down 5, from 300 as of 3/31/16
We do not know the disposition of those cases that have gone away, i.e., been dropped by plaintiffs who have given up or settled by Merck (which seems unlikely).
The reality is that this Fosamax – femur fracture status update sounds all too similar to the last one, and the one before that, etc.
- Eliquis Lawsuits Being Filed Across The Country In Increasing Numbers
- Bayer Essure Birth Control: Safety, Regulatory, And Legal Developments
- Farxiga / Jardiance / Invokana: Label Change Adds Ketoacidosis Warning
- Antidote Drug For Xarelto / Savaysa / Eliquis Is Denied FDA Approval
- Prolia & Xgeva: QT Interval Prolongation Associated With Hypocalcemia
- Viagra, Nexium, And Invokana: Drug Injury Lawsuits Report: Summer 2016
- Invokana / Farxiga / Jardiance: UTIs Then Urosepsis And Pyelonephritis